Open Access

High fluid shear stress prevents atherosclerotic plaque formation by promoting endothelium denudation and synthetic phenotype of vascular smooth muscle cells

  • Authors:
    • Juan Wang
    • Yan Wang
    • Lin Sheng
    • Tian He
    • Xiang Nin
    • Aiying Xue
    • Hua Zhang
    • Zhendong Liu
  • View Affiliations

  • Published online on: June 13, 2021     https://doi.org/10.3892/mmr.2021.12216
  • Article Number: 577
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Low blood fluid shear stress (SS) promotes vascular remodeling and atherosclerosis; however, the effects of high (H)SS on vascular remodeling and atherogenesis is not fully clarified. The major goal of this study was to investigate the role of HSS in atherosclerotic plaque formation. A perivascular SS modifier was implanted in the right carotid artery of apolipoprotein E (ApoE)‑/‑ mice to induce HSS, whereas the left carotid artery represented undisturbed (U)SS as a control in vivo. In vitro modeling used human umbilical vein endothelial cells and vascular smooth muscle cells exposed to HSS (2.5 Pa) using a parallel‑plate flow system. The results demonstrated that there were no plaque formations or endothelial cells in the HSS regions of the carotid artery in ApoE‑/‑ mice. The number of umbilical vein endothelial cells was markedly decreased in a time‑dependent manner in HSS. HSS significantly decreased α‑smooth muscle actin and increased osteopontin protein expression levels compared with USS in vascular smooth muscle cells (P<0.05). In addition, HSS significantly increased the protein expression levels of collagen α1(XVIII) chain/endostatin and matrix metalloproteinase‑8 in vascular smooth muscle cells. These data indicated that HSS may prevent atherosclerotic plaque formation through endothelium denudation and contractile‑to‑synthetic phenotypic conversion of smooth muscle cells.

Introduction

Vascular wall shear stress (SS) is crucially important in regulating vascular physiology and pathobiology of the vessel wall in atherosclerosis (1). Low (L)SS promotes vascular inflammation and atherosclerosis, whereas high (H)SS is protective (27). Although there have been a number of studies on endothelial cell (EC) responses in LSS environments, little attention has been devoted to understanding the role of HSS in atherosclerosis or atherosclerotic plaque formation (8).

HSS, usually regarded as >2.5Pa, has been reported to contribute to adaptive outward remodeling, pathological remodeling leading to saccular aneurysm initiation and instability of atherosclerotic plaques (9). Cheng et al (10) developed a perivascular SS modifier, referred to as a cast, that induced changes in SS patterns in apolipoprotein E (ApoE)-deficient mice. They found that atherosclerotic lesions developed in the LSS region, whereas no atherosclerotic lesions were found in the HSS region.

Vascular ECs are exposed to hemodynamic forces under normal physiological conditions. A previous study demonstrated that early-stage atherosclerosis is characterized by endothelial dysfunction (11). ECs are sensors of blood fluid SS and transduce the frictional force from blood flow into biochemical signals that regulate gene expression and cell behavior through specialized pathways, such as caveolae or caveolin-1 (8). Endothelial dysfunction in atherosclerosis impairs endothelium-dependent vasodilation and may lead to other pathophysiological consequences, such as increased chemotactic and adhesion molecule expression (12), increased monocyte/macrophage recruitment and accumulation, decreased EC regeneration, and increased vascular smooth muscle cells (VSMCs) proliferation and migration. However, it is unknown whether VSMC phenotype affects EC properties during vascular remodeling and endothelium recovery. The aim of the present study was to investigate the effects of HSS on ECs and VSMCs and to explore the potential mechanism of HSS on the vessel remodeling.

Materials and methods

Animal models

Male ApoE−/− mice (n=40; age 8 weeks; weight, 25–30 g) were obtained from the Key Laboratory of Cardiovascular Remodeling and Function Research of Shandong University. Among them, 15 mice were used for histological section, 16 mice were used for molecular biological detection and nine mice were used for Oil Red of vessel. The specific-pathogen free mice were housed at a constant temperature (24°C) and humidity (50-60%), fed a high-fat Western-type diet containing 0.25% cholesterol and provided water ad libitum. All experiments were performed in compliance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85–23, revised 1985) and Shandong University. The experimental protocol was approved by the institutional animal ethics committee at the Second Hospital of Shandong University [Shandong, China; KYLL-2019(KJ)P-0161].

SS modifier placement

A cast was used to induce standardized changes in SS in vivo as previously described (10,13). Mice were anesthetized by intraperitoneal injection of 0.08% sodium pentobarbital (40 mg/kg) prior to SS modifier placement surgery. The cast was implanted in the right carotid artery of ApoE−/− mice and imposed a fixed geometry on the vessel wall that caused gradual stenosis. Consequently, the blood flow in the vessel segment inside the cast increased and SS was elevated (HSS region). Conversely, the blood flow upstream from the cast decreased and SS was lowered (LSS region). The blood flow in a straight segment of the contralateral left carotid artery without cast was undisturbed SS (USS region); this served as a control.

Tissue harvesting

To compare the effects of the three types of SS on the carotid lesion, 40 mice were humanely killed at 10 weeks after cast implantation. The mice were deeply anesthetized with 5.0% sevoflurane and then euthanized by exsanguination by aspirating the blood from the left ventricle. After collecting blood through heart puncture, a reservoir perfusion apparatus that allowed direct manipulation of perfusion pressure was used to perfuse the vessel. Vessels were perfused with PBS at a constant physiological pressure of 100 mmHg, then constant pressure perfusion in situ with 4% polyformaldehyde. The bilateral common carotid arteries were carefully removed and fixed them in 4% polyformaldehyde overnight at 4°C. After carefully removing the cast, the three different SS regions of each mouse were classified, and the tissues (n=15) were embedded in paraffin compound for serial cryosections at room temperature.

Human umbilical vein endothelial cells (HUVECs) in HSS

An in vitro HSS model was established HUVECs [purchased from the American Type Culture Collection (ATCC)] in endothelial cell medium containing 5% FBS (cat. no. 1001; Sciencell Research Laboratories, Inc.), as previous described (1315). Controlled with USS, HSS (2.5 Pa) was imposed to HUVECs for 1–2 h using a parallel-plate flow system after HUVECs were cultured up to the fourth passage with 1×106 per plate. The viability of HUVECs was assessed using an MTT assay (Sigma-Aldrich; Merck KGaA; M2128-1G) with DMSO for dissolving crystals and a microplate reader at the wavelength 570 nm, according to the manufacturer's instructions.

Histological and immunofluorescence staining

Serial cryosections (6 µm) were stained with hematoxylin and eosin (Harris 5 g/l; Sigma-Aldrich; Merck KGaA) at room temperature for 30 min. Consecutive sections were stained with Sirius red (1.0 g/l; Beyotime Institute of biotechnology) for collagen and muscle fibers were stained using Masson Trichrome staining solution (10 g/l; Sigma-Aldrich; Merck KGaA) at room temperature for 60 min. Oil-red O (5.0 g/l; Sigma-Aldrich; Merck KGaA) staining was used to identify lipid-rich lesions at room temperature for 30 min. Aortic arches and carotid arteries were stained with Oil Red O for atherosclerotic lesions in the LSS region. The stained cryosections were imaged and analyzed using the Image-Pro Plus 6.0 automated image analysis system (Media Cybernetics, Inc.) attached to a color CCD video camera (fluorescent; ×50-1,000; Olympus BX51; Olympus Corporation). Intima was defined as the area bounded by the endothelium and the internal elastic lamina and media were defined as the area bounded by the internal and external elastic laminae (16).

Tissue sections were also used for immunofluorescence staining using antibodies against mouse CD31 (1:500; cat. no. sc-376764; Santa Cruz Biotechnology, Inc.), collagen α1(XVIII) chain (COL18A1; 1:500; cat. no. ab275746; Abcam), matrix metalloproteinase (MMP-8; 1:500; cat. no. PA5-79687; Invitrogen; Thermo Fisher Scientific, Inc.) overnight at 4°C. The secondary antibodies were Alexa 488-conjugated donkey anti-rabbit IgG (1:2,000; cat. no. A32790; Invitrogen; Thermo Fisher Scientific, Inc.) and Alexa 568-conjugated donkey anti-goat IgG (1:2,000; cat. no. A11057; Invitrogen; Thermo Fisher Scientific, Inc.). Images were acquired using an LSM710 laser scanning confocal microscope (Zeiss AG).

Following HSS exposure, cultured HUVECs were fixed with 4% paraformaldehyde and probed with rabbit anti-CD31 (1:1,000 dilution; cat. no. sc-376764; Santa Cruz Biotechnology, Inc.), and VSMCs (ATCC) with rabbit anti-COL18A1 (1:500 dilution; cat. no. ab275746; Abcam), MMP-8 (1:800 dilution; cat. no. PA5-79687; Invitrogen; Thermo Fisher Scientific, Inc.) overnight at 4°C. VSMCs were cultured with the supernatant of HUVECs. Then, they were stained with FITC-conjugated goat anti-rabbit IgG (1:200; cat. no. TA130021; OriGene Technologies, Inc.) polyclonal antibodies for 30 min at 37°C. Counterstaining for the nuclei was performed by incubating with DAPI (cat. no. D3571; Invitrogen; Thermo Fisher Scientific, Inc.) for 5 min at room temperature. Images were acquired with a laser scanning confocal microscope.

Western blot assay

Proteins were extracted from 50 mg carotid artery specimens of LSS, HSS and USS regions using lysis buffer (cat. no. P0013; Beyotime Institute of Biotechnology). Equal amounts of protein (20 µl) were separated on 10% SDS-PAGE and transferred to a nitrocellulose membrane (Bio-Rad Laboratories, Inc.). After being blocked with 5% non-fat milk for 2 h at room temperature, the blots were washed in TBS + 0.05% Tween-20 (TBS-T) three times for 10 min each and incubated at 4°C overnight with an appropriate primary antibody: Rabbit anti-β-actin (1:500; cat. no. AF5006; Beyotime Institute of Biotechnology), rabbit anti-CD31 (1:1,000; cat. no. sc-376764; Santa Cruz Biotechnology, Inc.), rabbit anti-α-smooth muscle actin (SMA; 1:1,000; cat. no. 144-60525-100; RayBiotech, Inc.), rabbit anti-osteopontin (OPN; 1:500; cat. no. 119-10057; RayBiotech, Inc.), rabbit anti-COL18A1 (1:500; cat. no. ab275746; Abcam), rabbit anti-MMP8 (1:1,000; cat. no. PA5-79687; Invitrogen; Thermo Fisher Scientific, Inc.). Following incubation, the blots were washed with TBS-T and incubated with horseradish peroxidase-conjugated secondary antibody (1:5,000; cat. no. sc-2357; Santa Cruz Biotechnology, Inc.) for 2 h at room temperature. The membranes were washed three times with TBS-T, and protein expression were visualized by Digital Gel Imaging system (AlphaEaseF™ software; serial 2200; ProteinSimple) with enhanced chemiluminescence detection reagents (Merk KGaA).

ELISA

HSS was used on HUVECs for 2 h. The supernatant obtained from HUVECs with different shear stress (USS, HSS, LSS) was harvested for culturing the VSMCs. The concentrations of endostatin (ES; a fragment of COL18A1) and MMP-8 were determined by using commercially available ELISA kits (cat. no. ab-281282; Abcam) following the manufacturer's protocol. Either a monoclonal antibody of ES or MMP-8 rom the kit was added to the assay diluents (100 µl). The plates were incubated for 2 h at 37°C. Each well was washed three times with wash buffer. The substrate solution (200 µl) was added for 30 min to stop the reaction. The optical density was determined with a microplate reader at the wavelength 450 nm.

Statistical analysis

The experiments were repeated three times. SPSS version 16.0 (SPSS Inc.) was used for statistical analysis. Data are expressed as the mean ± standard deviation. Statistical evaluation was carried out by two-tailed unpaired Student's t-test between two groups or by one-way ANOVA with Bonferroni's post hoc test among three groups. P<0.05 was considered to indicate a statistically significant difference.

Results

HSS reduces atherosclerotic plaque formation in ApoE−/− mice

Plaque formation was assessed by HE and Oil Red O staining (Fig. 1A). No plaque formations were detected in the HSS and USS regions, whereas plaque formation and fat content were observed in the LSS region in all 15ApoE−/− mice (Fig. 1A and B). The intima-media ratio in the HSS region was significantly lower compared with the USS region, and decreased to near zero (P<0.001; Fig. 1C). The ratio in the LSS region was significantly higher compared with that in the USS or HSS regions (both P<0.05).

HSS attenuates the vascular ECs and CD31 expression in mice

CD31, also known as platelet endothelial cell adhesion molecule, has been used as an EC marker. Compared with the normal expression of CD31 in USS regions with intact endometrium, the expression levels of CD31 were increased in LSS (Fig. 2A). Compared with the normal expression of ECs in the LSS and USS regions, there were fewer ECs, or almost no ECs detected by immunofluorescence in the HSS regions (Fig. 2A). CD31 protein expression levels were assessed by western blotting and were significantly decreased in the HSS region and significantly increased in the LSS region compared to the USS region (P<0.001; Fig. 2B and C).

HSS decreases the number of HUVECs in a time-dependent manner

HUVECs were stimulated by HSS for 0, 1 and 2 h. The CD31 expression in intensity over time was detected via western blotting using equal numbers of ECs, while EC numbers were counted. CD31 immunofluorescence and MTT demonstrated that the counts of HUVECs were markedly decreased in a time-dependent manner (Fig. 3A and B, respectively). CD31 protein expression levels in ECs were assessed using western blotting after the HUVECs were stimulated by HSS for 2 h; no significant difference was identified (P>0.05; Fig. 3C and D).

Collagen content and synthetic phenotype of VSMCs are enhanced by HSS

Given the crucial role in atherogenesis, collagen content and VSMC phenotype were examined in the HSS, LSS and USS regions. The collagen contents and VSMCs were determined using Sirius red and Masson's Trichrome staining. Collagen content was increased and the VSMC content were decreased in the HSS region compared with the USS region, although the differences were not significant (P>0.05; Fig. 4A-C). To explore the effects of HSS on the VSMC phenotype, the expression of α-SMA and OPN, which are widely used to determine VSMC phenotype (17,18), were examined by western blotting. Fig. 4D and F showed the α-SMA expression in contractile phenotype of VSMCs, and OPN expression in synthetic phenotype of VSMCs. α-SMA protein expression level was significantly lower and OPN expression was higher in the HSS region compared with expression in the USS region (both P<0.001; Fig. 4D-F). It indicated that HSS could induce the conversion of VSMCs from the contractile phenotype (α-SMA) to synthetic phenotype (OPN).

HSS promotes the expression of vascular COL18A1 and MMP-8 in mouse carotid arteries

To verify the activity of synthetic VSMCs induced by HSS, the protein expression levels of COL18A1 and MMP-8 in carotid arteries were determined using immunofluorescence (Fig. 5A and B) and western blotting (Fig. 5C). The expression levels of COL18A1 and MMP-8 were significantly higher in the HSS region compared with the USS region, as detected by western blotting (P<0.001; Fig. 5D and E).

HSS induces higher levels of COL18A1/ES and MMP-8 in VSMCs

To further confirm the activity of synthetic VSMCs, VSMCs were exposed to HSS for 2 h and the expression levels of COL18A1 and MMP-8 were detected using immunofluorescence and the supernatant concentrations of ES and MMP-8 were measured using ELISA. ES is a fragment of COL18A1 and regarded as a possible surrogate marker for subclinical atherosclerosis with basement membrane degradation (19,20). The expression levels of COL18A1 and MMP-8 in the VSMCs were increased by HSS (Fig. 6A and B). The supernatant concentrations of COL18A1 and MMP-8 were significantly higher after HSS 2 h compared with USS (P<0.001; Fig. 6C and D).

Discussion

Physiological laminar SS serves a crucial role in vascular function (1). To investigate the possible role of HSS on vascular remodeling, EC function and VSMC phenotype conversion induced by HSS was determined. The major findings of the present study were that HSS i) reduced/inhibited carotid plaque formation in ApoE−/− mice; ii) decreased EC counts and attenuated CD31 expression; and iii) induced the conversion of VSMCs from the contractile phenotype to synthetic phenotype.

In this study, no atherosclerotic plaque and low intima-media ratio were found in the HSS region as well as in the USS region in the carotid artery of ApoE−/− mice. These data indicated that HSS may prevent atherosclerotic plaque formation. In addition, experimental results showed that ECs were not detected and the expression of CD31 was low in the HSS region of the carotid artery of ApoE−/− mice. However, in vitro experiments showed that HSS did not induce changes in CD31 expression of HUVECs, although the number of HUVECs was significantly decreased by HSS. These results, at least to some extent, coincide with previous studies (4,21,22). Thus, it was suggested that preventing atherosclerotic plaque formation by HSS resulted from endothelial denudation rather than the conversion of the ECs phenotype. Lipid infiltration or deposition, which is a distinguishing feature of atherosclerosis and atherosclerotic plaque, is closely related to endothelial dysfunction (2). After endothelial denudation, the EC monolayer is removed and the subintimal lipid-binding may be prevent (23). Finally, the formation of atherosclerosis and atherosclerotic plaque is limited.

Conversely, results from the present study found that LSS increased CD31 expression, which was consistent with our previous study (13). Results from the previous study demonstrated that CD31 may be a major mechanoreceptor of LSS for activation of JNK followed by NF-κB and vascular cell adhesion protein 1 (13). LSS is known to increase EC inflammatory response, proliferation and apoptosis leading to the occurrence and development of atherosclerosis. CD31, also called platelet endothelial cell adhesion molecule1, is one of important member of the immunoglobulin superfamily (13). Thus, LSS may induce the upregulation of CD31 expression in ECs.

VSMCs and ECs are in close contacted with each other in blood vessels (24). VSMCs could be modulated by the ECs, which are directly exposed to the blood flow. Normal laminar SS modulate neointima accumulation (25). However, HSS was previously demonstrated to promote certain cellular responses, such as metalloproteinase activity to degrade matrix components, VSMC apoptosis and reduced matrix synthesis (26). In the present study, α-SMA expression was found to be significantly decreased whereas OPN expression was remarkably increased by HSS compared with USS. It indicated that HSS may induce VSMCs to convert from a contractile to a synthetic phenotype.

In the present study, the secretory activity of VSMCs was activated by HSS. Moreover, the concentrations of COL18A1/ES and MMP-8 were significantly elevated by HSS. ES is universally regarded as a circulating angiostatic factor derived from the cleavage of COL18A1 (2729) and has dramatic effects on EC gene expression as well as the capacity to inhibit EC migration, proliferation and survival (2933). Elevated circulating ES closely correlates with adverse pulmonary hemodynamics in pulmonary arterial hypertension (28,34). COL18A1/ES expression was reported to be significantly increased in the intima and media of remodeled vessels (34). MMP-8 expression is correlated with atherosclerotic lesion formation and progression (3538). A previous study demonstrated that the knockdown of MMP-8 in HUVECs results in a decrease in capillary-like network formation, cell proliferation and migration, and impaired the capacity of in vivo angiogenesis (38). Elevated ES levels may result from vasculature basement membrane degradation (39).

In the present study, a cast was used to induce HSS, which may have limited carotid vasodilative activity. This might be the reason why there was no carotid artery lumen enlargement, aneurysm or dissection in ApoE−/− mice. However, the results are consistent with previous studies showing that HSS and elevated COl18A1/ES are risk factors for artery aneurysm and dissection with pathological increscent of synthetic phenotype VSMCs (4042), which showed the same results of pathologic intimal denudation in arterial vessels. A major limitation to the present study is that the potential pathways of COL18A1/ES and MMP-8 in EC denudation and VSMC phenotypic conversion induced by HSS were not investigated. In addition, the apoptosis of ECs stimulated by HSS has not been discussed in the current study. These questions will be the focus of further research.

In summary, the results of the present study indicated that HSS may prevent atherosclerotic plaque formation. The probable mechanism is that HSS may induce endothelium denudation and contractile-to-synthetic phenotypic conversion of VSMCs. An improved understanding of the underlying mechanisms of SS in vessel remodeling would potentially lead to improving strategies for atherosclerotic disease management and novel targets for pharmacological intervention.

Acknowledgements

Not applicable.

Funding

This work was supported by The National Natural Science Foundation of China (grant nos. 81500232, 81670432 and 81973139); The Key Technology Research and Development Project of Shandong Province (grant nos. 2017GSF18169 and 2018GSF118044); The Shandong Provincial Natural Science Foundation (grant nos. ZR2020MH047 and ZR2017PH050). Funding bodies did not have any role in the design or performance of the study, nor in the interpretation of the results or writing of the manuscript.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

JW and ZL confirm the authenticity of all the raw data, and designed and conducted the study. JW, YW, LS, TH, XN, AX, HZ and ZL collected and analyzed the data. JW, HZ and ZL interpreted the data and wrote the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent to publication

Not applicable.

Competing interests

The authors declare that they have not competing interests.

Glossary

Abbreviations

Abbreviations:

ApoE

apolipoprotein E

EC

endothelial cell

ES

endostatin

HSS

high shear stress

HUVEC

human umbilical vein endothelial cell

MMP

matrix metalloproteinase

SS

shear stress

LSS

low shear stress

USS

undisturbed shear stress

VSMC

vascular smooth muscle cell

References

1 

Cunningham KS and Gotlieb AI: The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest. 85:9–23. 2005. View Article : Google Scholar : PubMed/NCBI

2 

Gijsen F, van der Giessen A, van der Steen A and Wentzel J: Shear stress and advanced atherosclerosis in human coronary arteries. J Biomech. 46:240–247. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Luong L, Duckles H, Schenkel T, Mahmoud M, Tremoleda JL, Wylezinska-Arridge M, Ali M, Bowden NP, Villa-Uriol MC, van der Heiden K, et al: Heart rate reduction with ivabradine promotes shear stress-dependent anti-inflammatory mechanisms in arteries. Thromb Haemost. 116:181–190. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Malek AM, Alper SL and Izumo S: Hemodynamic shear stress and its role in atherosclerosis. JAMA. 282:2035–2042. 1999. View Article : Google Scholar : PubMed/NCBI

5 

Liu Z, Zhao Y, Wang X, Zhang H, Cui Y, Diao Y, Xiu J, Sun X and Jiang G: Low carotid artery wall shear stress is independently associated with brain white-matter hyperintensities and cognitive impairment in older patients. Atherosclerosis. 247:78–86. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Chen Y, Yu H, Zhu J, Zhang H, Zhao Y, Dong Y, Cui Y, Gong G, Chai Q, Guo Y and Liu Z: Low carotid endothelial shear stress associated with cerebral vessel disease in an older population: A subgroup analysis of a population-based prospective cohort study. Atherosclerosis. 288:42–50. 2019. View Article : Google Scholar : PubMed/NCBI

7 

Zhao Y, Dong Y, Wang J, Sheng L, Chai Q, Zhang H and Liu Z: Longitudinal association of carotid endothelial shear stress with renal function decline in aging adults with normal renal function: A population-based cohort study. Sci Rep. 9:20512019. View Article : Google Scholar : PubMed/NCBI

8 

Brown AJ, Teng Z, Evans PC, Gillar JH, Samady H and Bennett MR: Role of biomechanical forces in the natural history of coronary atherosclerosis. Nat Rev Cardiol. 13:210–220. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Dolan JM, Kolega J and Meng H: High wall shear stress and spatial gradients in vascular pathology: A review. Ann Biomed Eng. 41:1411–1427. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Cheng C, Tempel D, van Haperen R, van der Baan A, Grosveld F, Daemen MJ, Krams R and de Croom R: Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation. 113:2744–2753. 2006. View Article : Google Scholar : PubMed/NCBI

11 

Chiu JJ and Chien S: Effects of disturbed flow on vascular endothelium: Pathophysiological basis and clinical perspectives. Physiol Rev. 91:327–387. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Zakkar M, Chaudhury H, Sandvik G, Enesa K, Luong LA, Cann S, Mason JC, Krams R, Clark AR, Haskard DO and Evans PC: Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis. Circ Res. 103:726–732. 2008. View Article : Google Scholar : PubMed/NCBI

13 

Wang J, An FS, Zhang W, Gong L, Wei SJ, Qin WD, Wang XP, Zhao YX, Zhang Y, Zhang C and Zhang MX: Inhibition of c-Jun N-terminal kinase attenuates low shear stress-induced atherogenesis in apolipoprotein E-deficient mice. Mol Med. 17:990–999. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Namdee K, Carrasco-Teja M, Fish MB, Charoenphol P and Eniola-Adefeso O: Effect of variation in hemorheology between human and animal blood on the binding efficacy of vascular-targeted carriers. Sci Rep. 5:116312015. View Article : Google Scholar : PubMed/NCBI

15 

Moriguchi T and Sumpio BE: PECAM-1 phosphorylation and tissue factor expression in HUVECs exposed to uniform and disturbed pulsatile flow and chemical stimuli. J Vasc Surg. 61:481–488. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Zhu Y, Farrehi PM and Fay WP: Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice. Circulation. 103:3105–3110. 2001. View Article : Google Scholar : PubMed/NCBI

17 

Wang J, Yan G, Guo H, Zhu Y, Shui X, He Y, Chen C and Lei W: ITE promotes hypoxia-induced transdifferentiation of human pulmonary aterial endothelial cells possibly by activating transforming growth factor-β/Smads and MAPK/ERK pathways. J Cell Biochem. 120:19567–19577. 2019. View Article : Google Scholar : PubMed/NCBI

18 

Nakamura H, Kitazawa K, Honda H and Sugisaki T: Roles of and correlation between alpha-smooth muscle actin, CD44, hyaluronic acid and osteopontin in crescent formation in human glomerulonephritis. Clin Nephrol. 64:401–411. 2005. View Article : Google Scholar : PubMed/NCBI

19 

Kato Y, Furusyo N, Tanaka Y, Ueyama T, Yamasaki S, Murata M and Hayashi J: The relation between serum endostatin level and carotid atherosclerosis in healthy residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS). J Atheroscler Thromb. 24:1023–1030. 2017. View Article : Google Scholar : PubMed/NCBI

20 

Ruge T, Carlsson AC, Kjøller E, Hilden J, Kolmos HJ, Sajadieh A, Kastrup J, Jensen GB, Larsson A, Nowak C, et al: Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study. Atherosclerosis. 284:202–208. 2019. View Article : Google Scholar : PubMed/NCBI

21 

Paszkowiak JJ and Dardik A: Arterial wall shear stress: Observations from the bench to the bedside. Vasc Endovascular Surg. 37:47–57. 2003. View Article : Google Scholar : PubMed/NCBI

22 

Dolan JM, Meng H, Singh S, Paluch R and Kolega J: High fluid shear stress and spatial shear stress gradients affect endothelial proliferation, survival, and alignment. Ann Biomed Eng. 39:1620–1631. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Franck G: Role of mechanical stress and neutrophils in the pathogenesis of plaque erosion. Atherosclerosis. 318:60–69. 2021. View Article : Google Scholar : PubMed/NCBI

24 

Tang R, Zhang G and Chen SY: Smooth muscle cell proangiogenic phenotype induced by cyclopentenyl cytosine promotes endothelial cell proliferation and migration. J Biol Chem. 291:26913–26921. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Palumbo R, Gaetano C, Antonini A, Pompilio G, Bracco E, Rönnstrand L, Heldin CH and Capogrossi MC: Different effects of high and low shear stress on platelet-derived growth factor isoform release by endothelial cells: Consequences for smooth muscle cell migration. Arterioscler Thromb Vasc Biol. 22:405–411. 2002. View Article : Google Scholar : PubMed/NCBI

26 

Slager CJ, Wentzel JJ, Gijsen FJ, Schuurbiers JC, van der Wal AC, van der Steen AF and Serruys PW: The role of shear stress in the generation of rupture-prone vulnerable plaques. Nat Clin Pract Cardiovasc Med. 2:401–407. 2005. View Article : Google Scholar : PubMed/NCBI

27 

Miosge N, Simniok T, Sprysch P and Herken R: The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo. J Histochem Cytochem. 51:285–296. 2003. View Article : Google Scholar : PubMed/NCBI

28 

Goyanes AM, Moldobaeva A, Marimoutou M, Varela LC, Wang L, Johnston LF, Aladdin MM, Peloquin GL, Kim BS, Damarla M, et al: Functional impact of human genetic variants of collagen 18A1/endostatin on pulmonary endothelium. Am J Respir Cell Mol Biol. 62:524–534. 2020. View Article : Google Scholar : PubMed/NCBI

29 

Hutter R, Sauter BV, Reis ED, Roque M, Vorcheimer D, Carrick FE, Fallon JT, Fuster V and Badimon JJ: Decreased reendothelialization and increased neointima formation with endostatinoverexpression in a mouse model of arterial injury. Circulation. 107:1658–1663. 2003. View Article : Google Scholar : PubMed/NCBI

30 

O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR and Folkman J: Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:277–285. 1997. View Article : Google Scholar

31 

Dhanabal M, Ramchandran R, Waterman MJ, Lu H, Knebelmann B, Segal M and Sukhatme VP: Endostatin induces endothelial cell apoptosis. J Biol Chem. 274:11721–11726. 1999. View Article : Google Scholar : PubMed/NCBI

32 

Abdollahi A, Hahnfeldt P, Maercker C, Gröne HJ, Debus J, Ansorge W, Folkman J, Hlatky L and Huber PE: Endostatin's antiangiogenic signaling network. Mol Cell. 13:649–663. 2004. View Article : Google Scholar : PubMed/NCBI

33 

Kim YM, Jang JW, Lee OH, Yeon J, Choi EY, Kim KW, Lee ST and Kwon YG: Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res. 60:5410–5413. 2000.PubMed/NCBI

34 

Hoffmann J, Marsh LM, Pieper M, Stacher E, Ghanim B, Kovacs G, König P, Wilkens H, Haitchi HM, Hoefler G, et al: Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patients. Am J Physiol Lung Cell Mol Physiol. 308:L1002–L1013. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Herman MP, Sukhova GK, Libby P, Gerdes N, Tang N, Horton DB, Kilbride M, Breitbart RE, Chun M and Schönbeck U: Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: A novel collagenolytic pathway suggested by transcriptional profiling. Circulation. 104:1899–1904. 2001. View Article : Google Scholar : PubMed/NCBI

36 

Ye S: Putative targeting of matrix metalloproteinase-8 in atherosclerosis. Pharmacol Ther. 147:111–122. 2015. View Article : Google Scholar : PubMed/NCBI

37 

Laxton RC, Hu Y, Duchene J, Zhang F, Zhang Z, Leung KY, Xiao Q, Scotland RS, Hodgkinson CP, Smith K, et al: A role of matrix metalloproteinase-8 in atherosclerosis. Circ Res. 105:921–929. 2009. View Article : Google Scholar : PubMed/NCBI

38 

Zhang F, Li S, Song J, Liu J, Cui Y and Chen H: Angiotensin-(1–7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells. Atherosclerosis. 261:90–98. 2017. View Article : Google Scholar : PubMed/NCBI

39 

Sato Y: Endostatin as a biomarker of basement membrane degradation. J Atheroscler Thromb. 24:1014–1015. 2017. View Article : Google Scholar : PubMed/NCBI

40 

Spring S, van der Loo B, Krieger E, Amann-Vesti BR, Rousson V and Koppensteiner R: Decreased wall shear stress in the common carotid artery of patients with peripheral arterial disease or abdominal aortic aneurysm: Relation to blood rheology, vascular risk factors, and intima-media thickness. J Vasc Surg. 43:56–63. 2006. View Article : Google Scholar : PubMed/NCBI

41 

Osswald A, Karmonik C, Anderson JR, Rengier F, Karck M, Engelke J, Kallenbach K, Kotelis D, Partovi S, Böckler D and Ruhparwar A: Elevated wall shear stress in aortic type B dissection may relate to retrograde aortic type A dissection: A computational fluid dynamics pilot study. Eur J Vasc Endovasc Surg. 54:324–330. 2017. View Article : Google Scholar : PubMed/NCBI

42 

Holsti M, Wanhainen A, Lundin C, Björck M, Tegler G, Svensson J and Sund M: Circulating vascular basement membrane fragments are associated with the diameter of the abdominal aorta and their expression pattern is altered in AAA tissue. Eur J Vasc Endovasc Surg. 56:110–118. 2018. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

August-2021
Volume 24 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang J, Wang Y, Sheng L, He T, Nin X, Xue A, Zhang H and Liu Z: High fluid shear stress prevents atherosclerotic plaque formation by promoting endothelium denudation and synthetic phenotype of vascular smooth muscle cells. Mol Med Rep 24: 577, 2021
APA
Wang, J., Wang, Y., Sheng, L., He, T., Nin, X., Xue, A. ... Liu, Z. (2021). High fluid shear stress prevents atherosclerotic plaque formation by promoting endothelium denudation and synthetic phenotype of vascular smooth muscle cells. Molecular Medicine Reports, 24, 577. https://doi.org/10.3892/mmr.2021.12216
MLA
Wang, J., Wang, Y., Sheng, L., He, T., Nin, X., Xue, A., Zhang, H., Liu, Z."High fluid shear stress prevents atherosclerotic plaque formation by promoting endothelium denudation and synthetic phenotype of vascular smooth muscle cells". Molecular Medicine Reports 24.2 (2021): 577.
Chicago
Wang, J., Wang, Y., Sheng, L., He, T., Nin, X., Xue, A., Zhang, H., Liu, Z."High fluid shear stress prevents atherosclerotic plaque formation by promoting endothelium denudation and synthetic phenotype of vascular smooth muscle cells". Molecular Medicine Reports 24, no. 2 (2021): 577. https://doi.org/10.3892/mmr.2021.12216